If approved, Eli Lilly is projected to capture 25% of the $11.3 billion Alzheimers treatment market in 2028, which would make it the second-highest grossing company in the Alzheimers treatment space
Red blood cell formation and haematological support
Another major benefit of carnitine comes here
Nature 575 , 669673 (2019)
By purchasing this product, the buyer certifies that they are 21 years of age or older, represent a qualified research professional, institution, or laboratory, will not use this material for human consumption, veterinary applications, or any in vivo studies, and will comply with all applicable laws and regulations governing research materials
FDA Enforcement Actions and Safety Concerns In September 2025, the FDA issued over 50 warning letters to compounders marketing GLP-1 products as generic equivalents to FDA-approved drugs